Sun Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] Dr.
Dr.reddy's Laboratories Ltd is a Public incorporated on 24 February 1984. It is classified as Non-government company and is registered at Registrar of Companies, ROC Hyderabad. Its authorized share capital is Rs. 1,450,000,000 and its paid up capital is Rs. 834,091,330.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
Dr. Reddy's Laboratories | 1,200,201 followers on LinkedIn. We accelerate access to affordable and innovative medicines because Good Health Can’t Wait. | Dr. Reddy’s Laboratories Ltd. (BSE ...
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company...
5 days ago · Hyderabad-based Dr. Reddy’s Laboratories has announced the signing of a non-exclusive patent licensing agreement with Japanese drug maker Takeda Pharmaceutical Company. This collaboration aims to introduce Vonoprazan tablets, a novel treatment for gastrointestinal disorders, to patients across India.
5 days ago · India Business News: HYDERABAD: Dr Reddy’s Laboratories Ltd has entered into a non-exclusive patent licensing pact with Japan’s Takeda Pharmaceutical Company Limited (Take.
5 days ago · Dr Reddy's Laboratories Ltd (RDDA:DUS) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
Dr. Reddy’s has grown steadily from its origins in bulk drug manufacturing into an integrated global pharmaceutical enterprise. Our business is anchored in our purpose of accelerating access to affordable medicines for patients around the world.
